Stephen L. Holcombe
2021
In 2021, Stephen L. Holcombe earned a total compensation of $1.9M as Former President and Chief Executive Officer at vTv Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Option Awards | $780,499 |
|---|---|
| Salary | $359,766 |
| Other | $770,996 |
| Total | $1,911,261 |
Holcombe received $780.5K in option awards, accounting for 41% of the total pay in 2021.
Holcombe also received $359.8K in salary and $771K in other compensation.
Rankings
In 2021, Stephen L. Holcombe's compensation ranked 6,204th out of 12,405 executives tracked by ExecPay. In other words, Holcombe earned more than 50.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,204 out of 12,405 | 50th |
Division Manufacturing | 2,627 out of 5,494 | 52nd |
Major group Chemicals And Allied Products | 1,145 out of 2,369 | 52nd |
Industry group Drugs | 1,019 out of 2,090 | 51st |
Industry Pharmaceutical Preparations | 737 out of 1,537 | 52nd |
Source: SEC filing on May 2, 2022.
Holcombe's colleagues
We found two more compensation records of executives who worked with Stephen L. Holcombe at vTv Therapeutics in 2021.
News
vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021
May 2, 2022
vTv Therapeutics CEO Stephen Holcombe's 2020 pay jumps 68% to $1.4M
March 18, 2021
vTv Therapeutics CEO Stephen Holcombe's 2019 pay jumps 81% to $833K
April 30, 2020
vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459K
March 15, 2019